Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe
Older age at initiation of antiretroviral therapy predicts low bone mineral density in children with perinatally-infected HIV in Zimbabwe
复制标题
DOI:
10.1016/j.bone.2019.05.012
复制
发表时间:
2019-08-01
期刊:
影响因子:
4.1
通讯作者:
Ferrand, Rashida A.
中科院分区:
文献类型:
--
作者:
Gregson, Celia L.;Hartley, April;Ferrand, Rashida A.
Background: Perinatally-acquired HIV infection commonly causes stunting in children; how this affects bone and muscle development is unclear. We investigated differences in bone and muscle mass and muscle function between children with HIV (CWH) and uninfected children. Setting: Cross-sectional study of CWH (6-16 years) receiving antiretroviral therapy (ART) for > 6 months and similar aged children testing HIV-negative at primary health clinics in Zimbabwe.Methods: From Dual-energy X-ray Absorptiometry (DXA) we calculated total-body less-head (TBLH) Bone Mineral Content (BMC) for lean mass adjusted-for-height (TBLH-BMCLBM) Z-scores, and lumbar spine (LS) Bone Mineral Apparent Density (BMAD) Z-scores.Results: The 97 CWH were older (mean age 12.7 vs. 10.0 years) and taller (mean height 142 cm vs. 134 cm) than 77 uninfected. However, stunting (height-for-age Z-score